Methodology Series Module 1 Cohort Studies
Methodology Series Module 1 Cohort Studies
Methodology Series Module 1 Cohort Studies
107]
How to cite this article: Setia MS. Methodology series module 1: Cohort
DOI: 10.4103/0019-5154.174011 studies. Indian J Dermatol 2016;61:21-5.
Received: December, 2015. Accepted: December, 2015.
We have clinical data from about 430 HIV‑infected subjective assessment or recall by the patient.
individuals in the center. The follow‑up period ranges For example, dietary history, smoking history, or
from 3 months to 4 years, and we know that 33 alcoholic history, etc. This may help in reducing the
individuals have died in this group. We decide to perform bias in measurement of exposure
the survival analysis in this group of individuals. We • A retrospective cohort study can be completed
prepare a clinical record form and abstract data from fast and is relatively inexpensive compared with a
these clinical forms. This design will be a retrospective prospective cohort study. However, it also has other
cohort study. strengths of the prospective cohort study.
biased toward the null, away from the null, or may be the first cardiovascular event. Thus, at the end of the
an appropriate estimate. 2nd year, 50 individuals have the outcome.
Follow‑up The total time contributed by these 50 individuals is
Follow‑up of the study participants is very important 50 × 2 years = 100 person years (PY) ‑ (A).
in a cohort study and losses are an important source of The total time contributed by the rest of the cohort
bias in these types of studies. Some patients are lost to is (10,000 − 50) × 10 = 99,500 PY ‑ (B).
follow‑up in large cohorts; however, if the proportion is
very high (>30%), then the validity of the results from Thus, the total person time is A + B = 99,600.
this study are doubtful. This loss to follow‑up becomes The incidence rate is 50/99,600 or 0.000502. As it is
all the more important if it is related to the exposure obvious from the term, this measure is a rate (compared
or outcome of interest. For example, in our prospective with cumulative incidence which was a proportion).
study, majority of the patients who were lost to Thus, the incidence rate of first cardiovascular event in
follow‑up had severe psoriasis at the baseline, then we psoriatic patients is 0.502/1000 PY or 5.02/10,000 PY.
will get biased estimates from the study. Thus, managing
follow‑ups and minimizing losses are an important Other analysis
component of the design of a cohort study. Other methods such as logistic regression, Kalpan–Meier
curves, cox‑regression, Poisson regression, lognormal
Nested case–control study regression may be useful in cohort studies. These are
This is a specific type of study design nested within relatively advanced analyses and should be discussed
a cohort study. In this, the investigator will match with a statistician.
the controls to the cases within a specific cohort. The
exposure of interest will be assessed in these selected Fixed and random effects models
cases and controls. For example, our hypothesis is One of the main strengths of a cohort study is the
that there is a biological marker that in present/ longitudinal nature of the data. Some of the variables
elevated (to begin with) in individuals who develop are time varying (such as blood pressure), and some
cardiovascular events in psoriatic patients. It is may be time independent (such as sex). The fixed and
expensive to assess this marker in all patients. Thus, random effects models are useful to handle longitudinal
we select all those who develop the outcomes (cases) data. The random effects model provides both
in our cohort and a sample of individuals who do not between‑ and within‑individual variance and is useful for
develop the outcomes (controls). An important aspect, time‑dependent and time‑independent variables. These
however, is that we should have stored the biological models are used in linear outcomes (such as body mass
material that we have collected at baseline, and the index) or categorical outcomes (such as presence/absence
biological marker should be assessed in this sample. of psoriasis). These are advanced modeling techniques
This procedure maintains the temporal strength of the and should be discussed with a statistician.
cohort study.
Some Practical Points
Analysis Project management
Cohort studies will help us to estimate the cumulative The investigator should remember that conducting a
incidence and incidence rate. large‑scale prospective cohort study requires proper
project management.
Cumulative incidence
Example Follow‑up of participants
We follow 10,000 psoriatic patients for 10 years. Of these, The investigator should devise strategies to ensure proper
50 have a cardiovascular event. Thus, the cumulative follow‑up of individuals at the designated time intervals.
incidence will be 50/10,000 or 0.005. This measure is a A computer program should be put in place at the start
proportion. Thus, the cumulative incidence will be 0.5% of the prospective study. The program should indicate the
or 5/1000. number of participants due for a visit every day. If the
individual does not visit for the next week, a reminder
Incidence rate should be sent to the individual. This can be performed
Example through texting or a phone call to the individual. Some
We follow‑up 10,000 psoriatic patients for 10 years. Of investigators hire field workers or outreach workers to
these, 50 have a cardiovascular event. ensure follow‑up of study participants.
How do we calculate the incidence rate? It is important that we include only patients with
Let us assume that all the cardiovascular events occurred permanent addresses in the area for long‑term cohort
at the end of the 2nd year. Our outcome of interest was studies. Details about the stay (permanent address,